Reducing the risk factors and enhancing the protective factors associated with initiating substance use.
Prevention
2nd International Workshop on the Strengthening Families Program
The different 'Strengthening Families Program' interventions around the world face similar challenges: cultural adaptation and fidelity, instruments of evaluation, validation of international adaptations, follow-up analysis, gender issues, incorporation of technologies in the implementation…
Human rights and youth playbook

Characteristics of Persons Who Inject Drugs and Who Witness Opioid Overdoses in Vietnam
19th International Congress on Addictions: "Dual Disorders and Comorbidity Associated with Substance Use"
In recent years, it has become evident that in order to better understand the phenomenon of psychoactive substance use and its implications for physical and mental health, a multidimensional approach is necessary, since there are many and varied aspects involved in the consumption of psychoactive substances and the development of addictions.

The Importance of Nutrition for Recovery from Addiction
Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs
Energy Drinks, Drug Use and the Developing Brain
Rates and Correlates of Binge Drinking among College Students with Disabilities
Symposium: "Women and drugs, challenges for prevention"
The National College extends a cordial invitation to the Symposium "Women and drugs, challenges for prevention", which will take place Monday, September 11, from 19:00 to 21:00 hours (time of the city of Mexico), at its facilities, located at number 104 of the Donceles Street, in the historic center of Mexico City.
6th International Symposium on Hepatitis Care in Substance Users
This symposium is the leading International conference focused on the management of hepatitis among substance users. It is organized by the International Network for Hepatitis in Substance Users (INHSU).
The International Symposium on Hepatitis in Substance Users attracts delegates including health professionals (doctors, nurses and allied health), researchers, community organisations, people who use drugs and policy makers.